+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Search Bar & Filters

Found 3 Actively Recruiting clinical trials

C

Actively Recruiting

Researchers are collecting detailed information about patients with venous thromboembolism VTE to improve understanding of this condition, especially in groups often excluded from clinical trials such as pregnant women, elderly patients, and those with severe health issues. This observational registry aims to provide data that can help reduce death rates, recurrences of blood clots, bleeding problems, and arterial events related to VTE. This study gathers clinical details about each patient, including other health conditions, and tracks the type, dose, duration, and results of antithrombotic treatments over the first three months. The registry is accessible online to assist doctors in managing complex cases by comparing patient profiles and identifying those at higher risk of complications. Participants clinical status and treatment outcomes are recorded, focusing on recurrence of VTE, bleeding events, and mortality over a three-year period. The information supports the creation of predictive scores to help healthcare providers identify patients at higher risk. The study started in 2001 and plans to continue until 2027, with ongoing data collection and follow-up.

All AgesAll Genders
305 locations
U

Actively Recruiting

Researchers are studying whether ultrasound-guided alcohol sclerotherapy can reduce pelvic pain and improve quality of life in women aged 18 to 45 diagnosed with ovarian endometriomas, compared to expectant management. Endometriosis is a common condition causing chronic pelvic pain and fertility issues, with ovarian endometrioma being the most frequent form. This trial aims to clarify if sclerotherapy offers better symptom relief and quality of life improvements than simply monitoring the condition. Participants will be randomly assigned to either receive ultrasound-guided alcohol sclerotherapy, where the cyst is punctured and treated with alcohol for 15 minutes followed by a wash, or to a control group receiving expectant management with standard pain care if needed. The study will compare these groups over 6 months, focusing on pain levels, quality of life, and fertility outcomes. During the study, participants will complete pain and quality of life assessments at the start and after 6 months. They will also provide blood and urine samples for biomarker analysis and undergo tests to assess ovarian reserve. Researchers will monitor adverse events, recurrence, pregnancy rates over about 2 years, and healthcare costs. The study uses rigorous analysis methods to assess the benefits and risks of the treatment.

Age: 18Years - 45YearsFEMALEPhase Not Applicable
27 locations
M

Actively Recruiting

Researchers are conducting a pre-screening study to identify individuals who may qualify for Roche interventional studies focused on Alzheimers disease. This study aims to assess potential eligibility by evaluating specific biomarkers and cognitive performance, helping to select suitable participants for future clinical trials related to Alzheimers disease. Participants will undergo testing to measure the concentration of pTau217 in their blood and complete the International Shopping List Test ISLT to assess cognitive function. There is no active treatment or intervention instead, the study collects these measurements to determine potential trial eligibility. During the study, participants will have blood samples drawn and complete cognitive assessments using the ISLT. Researchers will focus on the pTau217 biomarker levels and cognitive scores as primary outcomes measured on the first day of participation. This screening process helps identify candidates for subsequent interventional Alzheimers disease trials. The study is planned to run until July 2035 and includes adults aged 50 to 90 years.

Age: 50Years - 90YearsAll GendersPhase 3
234 locations